Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 16, 2020 - Issue
Submit an article Journal homepage
158
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Clinical Efficacy of Intravenous Immunoglobulin for BK Polyomavirus-Associated Nephropathy After Living Kidney Transplantation

Soichi Matsumura1 Department of Urology, Osaka University Graduate School of Medicine, Osaka565-0871, Japan
,
Taigo Kato1 Department of Urology, Osaka University Graduate School of Medicine, Osaka565-0871, Japan;2 Department of Urological Immuno-Oncology, Osaka University Graduate School of Medicine, Osaka565-0871, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8681-1407
ORCID Icon,
Ayumu Taniguchi1 Department of Urology, Osaka University Graduate School of Medicine, Osaka565-0871, Japan
,
Masataka Kawamura1 Department of Urology, Osaka University Graduate School of Medicine, Osaka565-0871, Japan
,
Shigeaki Nakazawa1 Department of Urology, Osaka University Graduate School of Medicine, Osaka565-0871, Japan
,
Tomoko Namba-Hamano3 Department of Nephrology, Osaka University Graduate School of Medicine, Osaka565-0871, JapanORCID Iconhttps://orcid.org/0000-0002-6049-7616
ORCID Icon,
Toyofumi Abe1 Department of Urology, Osaka University Graduate School of Medicine, Osaka565-0871, Japan
,
Norio Nonomura1 Department of Urology, Osaka University Graduate School of Medicine, Osaka565-0871, JapanORCID Iconhttps://orcid.org/0000-0002-6522-6233
ORCID Icon &
Ryoichi Imamura1 Department of Urology, Osaka University Graduate School of Medicine, Osaka565-0871, JapanORCID Iconhttps://orcid.org/0000-0002-8782-9852
ORCID Icon show all
Pages 947-952 | Published online: 08 Oct 2020

References

  • Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4(3):378–383. doi:10.1111/j.1600-6143.2004.00332.x
  • Kable K, Davies CD, O’connell PJ, Chapman JR, Nankivell BJ. Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin. Transplant Direct. 2017;3(4):e142. doi:10.1097/TXD.0000000000000641
  • Wunderink HF, De Brouwer CS, Gard L, et al. Source and relevance of the BK polyomavirus genotype for infection after kidney transplantation. Open Forum Infect Dis. 2019;6(3):ofz078. doi:10.1093/ofid/ofz078
  • Hirsch HH, Randhawa P. Practice AIDCo. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):179–188. doi:10.1111/ajt.12110
  • Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation. 2008;85(6):850–854. doi:10.1097/TP.0b013e318166cba8
  • Nickeleit V, Singh HK, Randhawa P, et al. The Banff Working Group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations. J Am Soc Nephrol. 2018;29(2):680–693. doi:10.1681/ASN.2017050477
  • Hirsch HH, Randhawa P. Practice ASTIDCo. BK virus in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S136–146. doi:10.1111/j.1600-6143.2009.02904.x
  • Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79(10):1277–1286. doi:10.1097/01.tp.0000156165.83160.09
  • Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008;41(1):11–18. doi:10.1038/sj.bmt.1705886
  • Bischof N, Hirsch HH, Wehmeier C, et al. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes. Nephrol Dial Transplant. 2019;34(7):1240–1250. doi:10.1093/ndt/gfy346
  • Chen XT, Li J, Deng RH, et al. The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy. Biosci Rep. 2019;39(2). doi:10.1042/BSR20182058
  • Lamarche C, Orio J, Collette S, et al. BK polyomavirus and the transplanted kidney: immunopathology and therapeutic approaches. Transplantation. 2016;100(11):2276–2287. doi:10.1097/TP.0000000000001333
  • Jolles S, Sewell WA, Misbah SA. Clinical uses of intravenous immunoglobulin. Clin Exp Immunol. 2005;142(1):1–11. doi:10.1111/j.1365-2249.2005.02834.x
  • Randhawa P, Pastrana DV, Zeng G, et al. Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK. Am J Transplant. 2015;15(4):1014–1020. doi:10.1111/ajt.13083
  • Pastrana DV, Brennan DC, Cuburu N, et al. Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathog. 2012;8(4):e1002650. doi:10.1371/journal.ppat.1002650
  • Vu D, Shah T, Ansari J, Naraghi R, Min D. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients. Transplant Proc. 2015;47(2):394–398. doi:10.1016/j.transproceed.2015.01.012

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.